Dendritic cells in networks of immunological tolerance

Tissue Antigens

Volumn 77, Issue 2, 2011, Pages 89-99

  Gregori, S ^a  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

FOXP3; Immunological tolerance; Interleukin 10; Regulatory T cells; Tolerogenic dendritic cells; Type 1 regulatory T cells

Indexed keywords

ANTIGEN PRESENTING CELL; BONE MARROW CELL; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE;

EID: 78650939162     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01615.x     Document Type: Review

References (58)

1. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973: 137: 1142-62.
2. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998: 392: 245-52.
3. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 2002: 99: 351-8.
4. Thomson AW. Tolerogenic dendritic cells: all present and correct? Am J Transplant 2010: 10: 214-9.
5. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev 2007: 7: 610-21.
6. Swiecki M, Colonna M. Accumulation of plasmacytoid DC: roles in disease pathogenesis and targets for immunotherapy. Eur J Immunol 2010: 40: 2094-8.
7. Gambineri E, Perroni L, Passerini L et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol 2008: 122: 1105-12, e1.
8. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006: 212: 28-50.
9. Dzionek A, Sohma Y, Nagafune J et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 2001: 194: 1823-34.
10. Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P. Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol 2000: 165: 4062-8.
11. Cao W, Bover L. Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol Rev 2010: 234: 163-76.
12. Martin-Gayo E, Sierra-Filardi E, Corbi AL, Toribio ML. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 2010: 115: 5366-75.
13. Hanabuchi S, Ito T, Park WR et al. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol 2010: 184: 2999-3007.
14. Gilliet M, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002: 195: 695-704.
15. Kadowaki N, Antonenko S, Lau JY, Liu YJ. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 2000: 192: 219-26.
16. Moseman EA, Liang X, Dawson AJ et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004: 173: 4433-42.
17. Kawamura K, Kadowaki N, Kitawaki T, Uchiyama T. Virus-stimulated plasmacytoid dendritic cells induce CD4+ cytotoxic regulatory T cells. Blood 2006: 107: 1031-8.
18. Manches O, Munn D, Fallahi A et al. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2, 3-dioxygenase-dependent mechanism. J Clin Invest 2008: 118: 3431-9.
19. Ito T, Yang M, Wang YH et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 2007: 204: 105-15.
20. Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005: 105: 1162-9.
21. Penna G, Sozzani S, Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 2001: 167: 1862-6.
22. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood 2002: 100: 4512-20.
23. Schakel K, Poppe C, Mayer E, Federle C, Riethmuller G, Rieber EP. M-DC8+ leukocytes - a novel human dendritic cell population. Pathobiology 1999: 67: 287-90.
24. Jongbloed SL, Kassianos AJ, McDonald KJ et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010: 207: 1247-60.
25. Maniecki MB, Moller HJ, Moestrup SK, Moller BK. CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes. Immunobiology 2006: 211: 407-17.
26. Gregori S, Tomasoni D, Pacciani V et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010: 116: 935-44.
27. Langerhans P. Ueber die Nervender menschlicher. Haut Virchows Arch (Pathol Anat) 1868: 44: 325.
28. Larregina AT, Falo LD Jr. Changing paradigms in cutaneous immunology: adapting with dendritic cells. J Invest Dermatol 2005: 124: 1-12.
29. Romani N, Clausen BE, Stoitzner P. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010: 234: 120-41.
30. Geissmann F, Dieu-Nosjean MC, Dezutter C et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002: 196: 417-30.
31. Morelli AE, Rubin JP, Erdos G et al. CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells. J Immunol 2005: 175: 7905-15.
32. Nickoloff BJ. Cutaneous dendritic cells in the crossfire between innate and adaptive immunity. J Dermatol Sci 2002: 29: 159-65.
33. Rescigno M, Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest 2009: 119: 2441-50.
34. Iliev ID, Spadoni I, Mileti E et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009: 58: 1481-9.
35. Dillon SM, Rogers LM, Howe R et al. Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation. J Immunol 2010: 184: 6612-21.
36. Demedts IK, Brusselle GG, Vermaelen KY, Pauwels RA. Identification and characterization of human pulmonary dendritic cells. Am J Respir Cell Mol Biol 2005: 32: 177-84.
37. Lambrecht BN, Hammad H. The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 2010: 376: 835-43.
38. Blois SM, Kammerer U, Alba Soto C et al. Dendritic cells: key to fetal tolerance? Biol Reprod 2007: 77: 590-8.
39. Laskarin G, Kammerer U, Rukavina D, Thomson AW, Fernandez N, Blois SM. Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells. Am J Reprod Immunol 2007: 58: 255-67.
40. Moreau P, Flajollet S, Carosella ED. Non-classical transcriptional regulation of HLA-G: an update. J Cell Mol Med 2009: 13: 2973-89.
41. Menier C, Rouas-Freiss N, Favier B, LeMaoult J, Moreau P, Carosella ED. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens 2010: 75: 201-6.
42. Liang S, Ristich V, Arase H, Dausset J, Carosella ED, Horuzsko A. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci U S A 2008: 105: 8357-62.
43. Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev 2010: 10: 753-66.
44. Bamboat ZM, Stableford JA, Plitas G et al. Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol 2009: 182: 1901-11.
45. Li G, Kim YJ, Broxmeyer HE. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential. J Immunol 2005: 174: 4706-17.
46. Rutella S, Bonanno G, Procoli A et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006: 108: 218-27.
47. Steinbrink K, Graulich E, Kubsch S, Knop J, Enk AH. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002: 99: 2468-76.
48. Pacciani V, Gregori S, Chini L et al. Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites. J Allergy Clin Immunol 2010: 125: 727-36.
49. Bacchetta R, Gregori S, Serafini G et al. Molecular and functional characterization of alloantigen-specific anergic T-cells suitable for cell therapy. Haematologica 2010 Dec; 95(12): 2134-43. Epub 2010 Aug 16.
50. Rossetti M, Gregori S, Roncarolo MG. Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naive T cells. Eur J Immunol 2010 Nov; 40(11): 3097-106. doi: 10.1002/eji.201040659. Epub 2010 Oct 19.
51. Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol 2009: 70: 345-52.
52. Anderson AE, Sayers BL, Haniffa MA et al. Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J Leukoc Biol 2008: 84: 124-33.
53. Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev 2009: 9: 324-37.
54. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev 2004: 4: 762-74.
55. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007: 449: 419-26.
56. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001: 193: 233-8.
57. Harry RA, Anderson AE, Isaacs JD, Hilkens CM. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis 2010: 69: 2042-50.
58. Moreau A, Hill M, Thebault P et al. Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. FASEB J 2009: 23: 3070-7.